Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

15. September 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2840


	Artikel 1 - 20 / 56790

	Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment. Cancer Lett Jiang S, Ren B, Ding C, Du C, Cao Z, Yang G, Huang H, Zhang T. PMID: 40945572 [PubMed - as supplied by publisher]
	KDM5C: A dual-edged epigenetic regulator in cancer biology-context-dependent roles and therapeutic implications. Biochem Pharmacol Tu FY, Liu YJ, Li X, Cao KF, Yu J, Wang R, Yang GJ, Chen J. PMID: 40945540 [PubMed - as supplied by publisher]
	Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial. Lancet Oncol Janssen QP, van Dam JL, van Bekkum ML, Bonsing BA, Bos H, Bosscha KP, Bouwense SAW, Brouwer-Hol L, Bruynzeel AME, Busch OR, Coene PLO, van Eijck CHJ, de Groot JWB, Haberkorn BCM, de Hingh IHJT, Karsten TM, Kazemier G, van der Kolk MB, Liem MSL, Loosveld OJL, Luelmo SAC, Luyer MDP, Mekenkamp LJM, Mieog JSD, Nieuwenhuijs VB, Nuyttens JJME, Patijn GA, van Santvoort HC, Stommel MWJ, Versteijne E, de Vos-Geelen J, de Wilde RF, Zonderhuis BM, van der Holt B, Homs MYV, van Tienhoven G, Besselink MG, Wilmink JW, Groot Koerkamp B, Dutch Pancreatic Cancer Group. PMID: 40945523 [PubMed - as supplied by publisher]
	From poor prognosis to precision promise: Clinical trials targeting BRAF-mutant metastatic colorectal cancer. Med Satake H, Bando H, Kobayashi S, Yoshino T. PMID: 40945506 [PubMed - in process]
	Cellular Cancer Immunotherapy in the Liver Transplant Population for HCC: An Attractive Therapeutic Option for the Next Decade. Clin Transplant Yu D, Li S, Chen H, Wang L. PMID: 40944927 [PubMed - in process]
	Ecological associations between gastric acid suppressant use and gastrointestinal cancer incidence: a three-decade global study. Ir J Med Sci Orayj K. PMID: 40944816 [PubMed - as supplied by publisher]
	Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study. Hepatol Res Ueno M, Takeda H, Takai A, Umeda M, Morimura H, Okuyama S, Nishijima N, Iwamoto S, Nakano S, Nagatomo S, Seta T, Goto T, Ikeda A, Kayahara T, Miyamoto S, Yazumi S, Ueo T, Uenoyama Y, Matsumura K, Mishima M, Inuzuka T, Eso Y, Takahashi K, Marusawa H, Osaki Y, Hatano E, Seno H. PMID: 40944673 [PubMed - as supplied by publisher]
	Role of Endoscopic Ultrasound (EUS) in the Era of Precision Medicine for Pancreatic Cancer Through Next-Generation Sequencing Technology. Int J Mol Sci Peserico G, Stornello C, Tessari M, Scapinello A, Curtarello M, Gruppo M, De Simoni O, Fantin A. PMID: 40943366 [PubMed - in process]
	Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) Skribek B, Szabó A, Ács J, Cavalcante BGN, Sipos BD, Hegyi P, Mátrai P, Nyirády P, Ács N, Majoros A, Deák PÁ. PMID: 40940959 [PubMed - in process]
	Pseudouridine Synthase 7 in Cancer: Functions, Mechanisms, and Therapeutic Potential. Cells Yang Q, Boyer TG, Al-Hendy A. PMID: 40940790 [PubMed - in process]
	Crucial roles of CircRNA-mediated autophagy in digestive cancer. Front Oncol Shi S, Wei A, Yang Y, Li J. PMID: 40936702 [PubMed - in process]
	The role of resistance training in mitigating cancer-induced cachexia: A systematic review. Sports Med Health Sci Horawski JL, Fleszar-Pavlovic SE, Lopez-Pentecost M, Crane TE, Wheeler MG, Kholodovsky E, Best TM. PMID: 40936667 [PubMed - in process]
	Oligometastatic disease in pancreatic cancer: is there a role for curative-intent surgery? A narrative review. Clin Transl Oncol Ramírez-Plaza CP, Roldón-Golet M, Pérez-Daga JA, Pereira-Pérez F. PMID: 40936060 [PubMed - as supplied by publisher]
	Prediction model for mutation detection via circulating tumor DNA analysis in pancreatic cancer. Pancreatology Suzuki R, Asama H, Shimizu H, Sato K, Osawa K, Ohira R, Kudo K, Sugimoto M, Ohira H. PMID: 40935782 [PubMed - as supplied by publisher]
	Driving Precision Medicine in Pancreatic Cancer With Molecular Genetics. Semin Radiat Oncol Farooq M, Pishvaian MJ. PMID: 40935446 [PubMed - in process]
	Emerging Systemic Therapy Considerations for Pancreatic Cancer. Semin Radiat Oncol Liang KL, Guo MZ, Zaidi N. PMID: 40935444 [PubMed - in process]
	Beyond Opioids in Pancreatic Cancer: Palliative Radiotherapy and Celiac Plexus Radiosurgery. Semin Radiat Oncol Miszczyk M, Abrams RA, Lawrence YR. PMID: 40935442 [PubMed - in process]
	Quality and Quantity: Dual Benefits of Ablative Radiation in Oligometastatic Pancreatic Cancer. Semin Radiat Oncol Aguilera TA, Elamir AM, Ludmir EB. PMID: 40935441 [PubMed - in process]
	Intraoperative Radiation for Pancreatic Cancer. Semin Radiat Oncol Elguindy A, Blakaj D, Grecula J, Miller ED. PMID: 40935440 [PubMed - in process]
	Optimal Target Volume Delineation for Pancreatic Cancer: Triangulating What Should be Targeted. Semin Radiat Oncol Narang A. PMID: 40935439 [PubMed - in process]

Artikel 1 - 20 / 56790

Seite 1 von 2840



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung